425: Strive & Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination, as confirmed by Strive's CEO Matthew Cole.

Summary

• Strive, Inc. and Semler Scientific, Inc. have entered into a merger agreement for a proposed business combination.
• The announcement was reposted on X.com by Matthew Cole, Chief Executive Officer of Strive, Inc., on September 24, 2025.
• The transaction is expected to yield strategic and financial benefits, including anticipated cost savings and strategic gains.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus.
• Stockholders of Semler Scientific will be asked to approve the proposed transaction.

Sentiment

Score: 7

Explanation: The announcement of a proposed business combination is generally a positive strategic move, indicating growth and potential synergies. However, the filing extensively details numerous risks associated with the transaction, integration, and market conditions, which tempers the overall positive sentiment.

Positives

• The proposed transaction is expected to bring strategic and financial benefits to the combined company.
• Anticipated cost savings and strategic gains are projected from the business combination.
• The merger aims to successfully integrate the combined businesses, potentially enhancing future financial performance.

Negatives

• Integration of the two companies may be more difficult, time-consuming, or costly than initially expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction will cause dilution.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships could occur.

Risks

• The merger agreement could be terminated by one or both parties.
• Conditions to closing the transaction may not be received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings instituted against Strive, Semler Scientific, or the combined company could be adverse.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks are associated with the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could impact the transaction.
• Changes in Strive's or Semler Scientific's share price before closing could affect the transaction.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed business combination, including successful integration and positive impacts on future financial performance. However, these forward-looking statements are subject to significant risks and uncertainties, including the realization of anticipated benefits and the timing of the transaction's closing.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., reposted the communication on X.com regarding the proposed business combination with Semler Scientific, Inc.

Industry Context

The proposed business combination includes risks associated with Bitcoin treasury strategies and other digital assets, indicating a strategic pivot or significant exposure to the evolving digital asset landscape, a trend observed in a growing number of companies seeking alternative treasury management or investment strategies. This positions the combined entity within a segment exploring innovative, albeit volatile, financial approaches.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a risk factor for the proposed transaction.

Related Party Transactions

• Semler Scientific's transactions with related persons are detailed in its definitive proxy statement in connection with its 2025 Annual Meeting of Stockholders, filed with the SEC on July 17, 2025.

Stakeholder Impact

• Shareholders of Strive face potential dilution due to the issuance of additional Class A common stock.
• Shareholders of Semler Scientific will be asked to approve the transaction, impacting their investment.
• Customers of both companies may have adverse reactions to the announcement or completion of the proposed transaction.
• Business and employee relationships could change as a result of the merger.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Recommendation

The proposed business combination presents potential strategic and financial benefits, but the filing also highlights numerous risks, including integration challenges, potential dilution, and the possibility that anticipated benefits may not be realized. Investors should hold pending the release of the Form S-4 and further details on the merger terms and financial projections to make an informed decision.

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Digital Assets, Corporate Governance, Financial Reporting